NCT00501735 2012-01-23
Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
BioCryst Pharmaceuticals
Phase 2 Completed
Clinical Trials
3 trialsNCT00289562 2012-01-20
Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia
BioCryst Pharmaceuticals
Phase 1/2 Completed
NCT00035022 2006-01-13
Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas
BioCryst Pharmaceuticals
Phase 1/2 Completed